Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of veterans affairs cooperative study
β Scribed by Daniel O. Clegg; Domenic J. Reda; Michael H. Weisman; John J. Cush; Frank B. Vasey; H. Ralph Schumacher Jr.; Elly Budiman-Mak; Dominic J. Balestra; Warren D. Blackburn; Grant W. Cannon; Robert D. Inman; F. Paul Alepa; Edwin Mejias; Miriam R. Cohen; Rama Makkena; Maren L. Mahowald; Jean Higashida; Stuart L. Silverman; Nourollah Parhami; Joel Buxbaum; Clair M. Haakenson; Richard H. Ward; B. J. Manaster; Robert J. Anderson; John R. Ward; William G. Henderson
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 616 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. To determine if the peripheral articular manifestations of the seronegative spondylarthropathies (SNSA) respond differently than the axial manifestations to treatment with sulfasalazine (SSZ). Methods. This is a reanalysis of a previously reported series of randomized, double-blind, plac
Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula
## Abstract The US Department of Veterans' Affairs (VA) conducted Cooperative Study #394 at nine sites to determine whether vitamin E was a safe and effective treatment for tardive dyskinesia (TD). The study used the Abnormal Involuntary Movement Scale (AIMS) to measure TD. To monitor interβrater r